Back to news
REGULATORYThe Marijuana Herald

FDA removes 510(k) requirement for qualifying cannabinoid drug tests

FDA expanded a Class II premarket-notification exemption to qualifying cannabinoid tests used in federal workplace and insurance testing programs, effective October 6. The change may lower a device-market barrier and support future oral-fluid testing, but Oklahoma employers and laboratories still must follow all other FDA and SAMHSA requirements.

Share this update

FacebookXLinkedInEmail

#national#testing#employment#compliance

Read the original source

Leafy summaries provide industry context. Confirm details with The Marijuana Herald.

Open source

Continue reading

Related industry updates